PHARMA DMS
0821.606.232 · rovalta.com · 22/09/2026
PHARMA DMS
Overview
What does PHARMA DMS do?
PHARMA DMS is a Private limited company incorporated in 2009. Its main activity is: Dispensing chemist in specialised stores. Its registered office is in Roeselare.
8800 Roeselare · FlandreSee on map
Joint committees (1)
- 313
Trend over 14 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||||||||||||||||||||
| Gross margin | 71,8 k € | +3.2% | 69,6 k € | +2.4% | 67,9 k € | +9.3% | 62,1 k € | +5.3% | 59 k € | +27.5% | 46,2 k € | -6.6% | 49,5 k € | -13.4% | 57,1 k € | -22.8% | 74 k € | -1.0% | 74,7 k € | +3.6% | 72,1 k € | -3.5% | 74,8 k € | -12.4% | 85,4 k € | +117% | 39,3 k € |
| EBITDA | 71,3 k € | +3.3% | 69 k € | +3.2% | 66,9 k € | +8.7% | 61,5 k € | +5.0% | 58,6 k € | +262% | 16,2 k € | -40.3% | 27,1 k € | -34.4% | 41,4 k € | -26.2% | 56 k € | -1.9% | 57,1 k € | -1.8% | 58,2 k € | -3.5% | 60,3 k € | -10.6% | 67,5 k € | +211% | 21,7 k € |
| Operating result | 71,3 k € | +3.3% | 69 k € | +3.2% | 66,9 k € | +8.7% | 61,5 k € | +5.0% | 58,6 k € | +3967% | -1,5 k € | -117% | 9,1 k € | -58.6% | 22 k € | -40.1% | 36,8 k € | +120% | 16,7 k € | -15.2% | 19,7 k € | -9.8% | 21,9 k € | -27.8% | 30,3 k € | +305% | -14,7 k € |
| Net result | 71,1 k € | +3.1% | 69 k € | +0.4% | 68,7 k € | +7.1% | 64,2 k € | +3.1% | 62,3 k € | +454% | -17,6 k € | -743% | -2,1 k € | -130% | 7 k € | -69.2% | 22,7 k € | +1068% | 1,9 k € | -40.3% | 3,3 k € | -17.7% | 4 k € | -61.7% | 10,3 k € | +134% | -30,1 k € |
| Balance sheet | |||||||||||||||||||||||||||
| Equity | 177,7 k € | +0.1% | 177,5 k € | +0.0% | 177,5 k € | +0.1% | 177,3 k € | +0.1% | 177,1 k € | +11.1% | 159,4 k € | -9.9% | 177 k € | -1.2% | 179,1 k € | +4.1% | 172,1 k € | +15.2% | 149,4 k € | +1.3% | 147,4 k € | +2.3% | 144,2 k € | +2.8% | 140,2 k € | +7.9% | 129,9 k € |
| Total assets | 355,3 k € | +6.3% | 334,2 k € | +34.9% | 247,7 k € | +1.6% | 243,8 k € | -0.5% | 245 k € | +26.4% | 193,8 k € | -34.7% | 296,6 k € | -4.2% | 309,5 k € | +1.8% | 303,9 k € | -1.3% | 308 k € | -6.2% | 328,3 k € | -9.6% | 363,2 k € | -2.2% | 371,3 k € | -7.3% | 400,7 k € |
| Cash | 221,6 k € | +12.4% | 197,1 k € | +88.3% | 104,7 k € | +5.0% | 99,7 k € | +19.9% | 83,2 k € | +66.3% | 50 k € | -61.2% | 128,9 k € | +5.8% | 121,7 k € | +31.8% | 92,3 k € | +11.0% | 83,2 k € | +25.1% | 66,5 k € | +14.6% | 58 k € | +109% | 27,7 k € | +22.6% | 22,6 k € |
| Debts | 177,6 k € | +13.7% | 156,2 k € | +123% | 70,2 k € | +5.5% | 66,6 k € | -2.0% | 67,9 k € | +97.3% | 34,4 k € | -70.1% | 114,9 k € | -11.9% | 130,4 k € | -0.7% | 131,4 k € | -12.9% | 150,9 k € | -12.2% | 171,8 k € | -21.5% | 219 k € | -5.2% | 231 k € | -14.7% | 270,7 k € |
| Other | |||||||||||||||||||||||||||
| Workforce | 0,0 ETP | 0,0 ETP | 0,0 ETP | – | – | 0,6 ETP | +50.0% | 0,4 ETP | 0.0% | 0,4 ETP | -20.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | 0.0% | 0,5 ETP | |||||
Indicative valuation
As an indication, this company is worth
Board of directors
Seen on filing of 31/12/2025 · 1 active · 6 ended
Other companies at this address
| Company | CBE no. |
|---|---|
CORTEXCO● Active | 0898.426.272 |
DERTIEN-ACHT● Active | 0883.202.420 |
GROEP WESTLAAN BTW EENHEID● Active | 1013.092.249 |
Westlaanapotheek● Active | 0859.788.697 |
Financials
Full financial information
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model | Abridged model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 10/07/2026 | 15/07/2025 | 12/07/2024 | 16/06/2023 | 09/06/2022 | 28/06/2021 |
| General meeting | 19/06/2026 | 30/06/2025 | 29/06/2024 | 19/05/2023 | 20/05/2022 | 11/06/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Looking for more information about this company?
Try for 7 daysAnnual accounts filings
16 filings with the NBB
| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Abridged model | 31/12/2025 | 19/06/2026 | 10/07/2026 | Dutch | |
| Abridged model | 31/12/2024 | 30/06/2025 | 15/07/2025 | Dutch | |
| Abridged model | 31/12/2023 | 29/06/2024 | 12/07/2024 | Dutch | |
| Abridged model | 31/12/2022 | 19/05/2023 | 16/06/2023 | Dutch | |
| Abridged model | 31/12/2021 | 20/05/2022 | 09/06/2022 | Dutch | |
| Abridged model | 31/12/2020 | 11/06/2021 | 28/06/2021 | Dutch | |
| Abridged model | 31/12/2019 | 26/06/2020 | 20/07/2020 | Dutch | |
| Abridged model | 31/12/2018 | 17/05/2019 | 04/07/2019 | Dutch | |
| Abridged model | 31/12/2017 | 30/06/2018 | 17/08/2018 | Dutch | |
| Abridged model | 31/12/2016 | 30/06/2017 | 28/08/2017 | Dutch | |
| Abridged model | 31/12/2015 | 30/06/2016 | 19/07/2016 | Dutch | |
| Abridged model | 31/12/2014 | 30/06/2015 | 04/08/2015 | Dutch | |
| Abridged model | 31/12/2013 | 30/06/2014 | 28/08/2014 | Dutch | |
| Abridged model | 31/12/2012 | 29/06/2013 | 06/08/2013 | Dutch | |
| Abridged model | 31/12/2011 | 30/06/2012 | 28/08/2012 | Dutch | |
| Abridged model | 31/12/2010 | 20/05/2011 | 25/08/2011 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Seen on filing of 31/12/2025 · 1 active · 6 ended
Ownership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
- Mandates10/01/2024STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - DIVERSEN - DOEL - ONTSLAGEN - BENOEMINGEN - ALGEMENE VERGADERING
- Mandates25/03/2019BENAMING - MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
- Mandates30/06/2015ONTSLAGEN - BENOEMINGEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
- Other22/12/2009RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
Source: Belgian Official Gazette
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202571,1 k €↑
- 2024Annual accounts 202469 k €↑
- 2023Annual accounts 202368,7 k €↑
- 2022Annual accounts 202264,2 k €↑
- 2021Annual accounts 202162,3 k €↑
- 2018Annual accounts 2018-17,6 k €↓
- 2018Name changePHARMA DMS
- 2017Annual accounts 2017-2,1 k €↓
- 2016Annual accounts 20167 k €↓
- 2015Annual accounts 201522,7 k €↑
- 2014Annual accounts 20141,9 k €↓
- 2013Annual accounts 20133,3 k €↓
- 2012Annual accounts 20124 k €↓
- 2011Annual accounts 201110,3 k €↑
- 2010Annual accounts 2010-30,1 k €
- 2010Name changeGRYSPEERDT & BERTRAND
- 18/12/2009IncorporationPrivate limited company